TL;DR
This paper explores the use of multiparametric MRI (MP-MRI) combined with MRI/ultrasound (US) fusion-guided biopsy to detect seminal vesicle invasion (SVI) in prostate cancer (PCa). The study demonstrates that this integrated approach can accurately identify SVI, potentially improving preoperative staging and patient counseling for T3b PCa.
What Problem Does This Paper Address?
Prostate cancer (PCa) staging is crucial for determining the best treatment strategy and predicting patient outcomes. Seminal vesicle invasion (SVI) is a significant indicator of more aggressive disease (T3b PCa) and is associated with poorer outcomes, including higher rates of biochemical recurrence after treatment. Historically, accurately detecting SVI before surgery has been challenging. Traditional methods like digital rectal exams (DRE), transrectal ultrasound (TRUS)-guided biopsies, and predictive nomograms have limitations in sensitivity and specificity. While multiparametric MRI (MP-MRI) has shown promise in detecting PCa, its specific role in identifying SVI and guiding biopsies to confirm it has been an area of active investigation. This paper aims to bridge this gap by evaluating the correlation between MP-MRI findings suggestive of SVI and the pathological confirmation obtained through MRI/US fusion-guided biopsy.
Methods
The study employed a prospective trial design involving 822 patients who underwent both MP-MRI and MRI/US fusion-guided biopsy. For patients with suspicious seminal vesicle findings on MP-MRI, targeted biopsies of these structures were performed.
The MP-MRI protocol utilized a 3 Tesla scanner with specific sequences including T2-weighted imaging, dynamic contrast-enhanced (DCE) imaging, diffusion-weighted imaging (DWI), and magnetic resonance spectroscopy (MRS). Two radiologists prospectively evaluated the MP-MRI data, assigning a suspicion level (low, moderate, or high) for SVI.
The MRI/US fusion-guided biopsy system integrated diagnostic MRI with real-time ultrasound images to precisely target suspicious lesions. For seminal vesicles identified as suspicious for SVI, at least two biopsy cores were obtained from both axial and sagittal planes.
Prostate biopsy results and radical prostatectomy (RP) pathology (when available) were reviewed by a single genitourinary pathologist for correlation. Data analysis included logistic regression for univariate analysis and descriptive statistics.
Datasets
The study utilized data from 822 patients who underwent MP-MRI and MRI/US fusion-guided biopsy at the National Cancer Institute (NCI) between March 2007 and June 2013. Of these, 25 patients had lesions suspicious for SVI and underwent targeted biopsy of the seminal vesicles, resulting in 31 biopsied targets. No new datasets were introduced; the study evaluated existing patient data.
Key Insights and Ideas
- MP-MRI as a powerful screening tool for SVI: The study reinforces MP-MRI's capability to identify potential seminal vesicle invasion, flagging specific areas for further investigation.
- Fusion-guided biopsy enhances diagnostic yield: Combining MRI with real-time ultrasound for biopsy guidance significantly improves the detection rate of SVI compared to relying solely on imaging or traditional biopsy methods.
- Targeted biopsy provides definitive staging: Obtaining tissue samples directly from suspicious seminal vesicles via fusion-guided biopsy offers a more definitive preoperative assessment of SVI, which is critical for accurate staging.
- Concordance with surgical pathology: In cases where patients underwent radical prostatectomy after targeted SV biopsy, the biopsy and surgical pathology results were concordant, validating the biopsy's accuracy.
- Impact on treatment planning: The ability to definitively diagnose or rule out SVI preoperatively can significantly influence patient counseling, treatment selection (e.g., surgery vs. radiation), and surgical planning, potentially avoiding unnecessary aggressive treatments or ensuring adequate surgical margins.
Key Results
- Out of 31 targeted seminal vesicle lesions suspicious for SVI on MP-MRI, MRI/US fusion-guided biopsy detected SVI in 20/31 (65%) of cases.
- When considering only moderate or high suspicion levels on MP-MRI, the detection rate of SVI was 71%.
- For the four patients who underwent radical prostatectomy after a preoperative assessment of SVI via biopsy, the biopsy pathology and RP pathology were 100% concordant.
- In one notable case, MRI/US fusion-guided biopsy significantly decreased a patient's preoperative staging from T3b to T2c, impacting their treatment decision.
- The study found that moderate or high MP-MRI suspicion for SVI led to histologic confirmation in 20/28 (71%) of cases, a statistically significant finding compared to low suspicion cases (0%).
Limitations and Future Work
- Limited sensitivity and NPV calculation: The study could not definitively calculate the sensitivity or negative predictive value (NPV) of MP-MRI and MRI/US fusion biopsy for SVI because patients with negative MRI findings were not routinely biopsied for seminal vesicles. This is partly due to the potential for protracted hematospermia and the fact that SV biopsy is not a standard procedure.
- Systemic therapy and radiation: A significant portion of the study cohort received systemic therapy and/or radiation rather than RP due to advanced disease. This limits the ability to verify SVI on final surgical pathology for all patients.
- Anatomical distortion and motion artifact: In some cases, MRI/US fusion-guided biopsy failed to yield SV or PCa tissue. This may be attributed to anatomical distortion of the SVs by prostate nerve blocks or the inherent mobility of the SVs, which can challenge accurate image registration and lead to motion artifact during biopsy.
- Future Work: The authors suggest that as this technology becomes more widely available, MP-MRI and MRI/US fusion-guided biopsy may play a crucial role in preoperative staging for PCa. Future research should focus on determining if improved preoperative staging leads to better surgical outcomes. They also propose that repeat image registration immediately before SV biopsy might improve accuracy.
Summary updated